NCT03104205

Brief Summary

The goal of this study is to conduct a program of pilot research aimed at developing and evaluating a technology-assisted wellness intervention for older adults with obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 7, 2017

Completed
1.5 years until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
5 months until next milestone

Results Posted

Study results publicly available

December 20, 2021

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

1.8 years

First QC Date

April 3, 2017

Results QC Date

August 25, 2021

Last Update Submit

June 9, 2023

Conditions

Keywords

frail elderlytelemedicineobesityrural healthhealth promotionweight loss

Outcome Measures

Primary Outcomes (5)

  • Change in Grip Strength

    Assessed by a Jamar dynamometer. Sensor-based Thera-bands will measure data on strength change.

    Change between baseline and follow-up at 26-weeks

  • Change in 30 Second Sit-to-Stand (STS)

    STS measures lower limb strength - change represented as repetitions.

    Change between baseline and follow-up at 26-weeks

  • Change in Six-Minute Walk Test (6MWT)

    A surrogate for cardiovascular fitness that measures distance (normal 400-700m) related to function. A clinically important difference is 50-55m

    Change between baseline and follow-up at 26-weeks

  • Change in Gait Speed (Meters Per Second)

    Gait speed is measured by the time it takes to walk 20 meters. Gait speed predicts disability and mortality (a significant change is considered 0.1 meters per second).

    Change between baseline and follow-up at 26-weeks

  • Change in Late-Life Function and Disability Instrument (LLFDI)

    LLFDI consists of a 32-item function and 16-item disability (life-task) scales that correlate with gait speed and lower limb function. For this instrument we use only the 32-item function and scores are scaled. Minimum 0, Maximum 100. Higher scores indicate higher levels of function

    Change between baseline and follow-up at 26-weeks

Secondary Outcomes (9)

  • Behavioral Activation (Patient Activation Measure)

    baseline and follow-up at 26-weeks

  • Subjective Health Status (PROMIS)

    Change between baseline and follow-up at 26-weeks

  • Change in Weight in kg

    Change between baseline and follow-up at 26-weeks

  • Change in Body Mass Index (BMI) in kg/m^2

    Change between baseline and follow-up at 26-weeks

  • Change in Waist Circumference in cm

    Change between baseline and follow-up at 26-weeks

  • +4 more secondary outcomes

Study Arms (1)

Evaluate home-based MOWI

EXPERIMENTAL

Conduct and assess the feasibility, acceptability, and potential effectiveness of home-based MOWI in improving physical function.

Behavioral: Evaluate home-based MOWI

Interventions

MOWI will be delivered via video-conferencing in the subject's home in a 3x per week, 26-week program from the coordinating center. It will include an individual dietician-led weekly nutrition session; 2x/week physical therapist-led group exercise session; and remote fitness device monitoring. We plan 5 cohorts of 8 subjects (n=40). In-person Research Assistant-led assessments will occur at 0, 8, 16 and 26 weeks. Recruitment, screening, selection criteria, and usability parallel Aim 2 (NCT03104192).

Evaluate home-based MOWI

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥65 years
  • Body Mass Index (BMI) ≥ 30kg/m\^2 OR Waist circumference ≥88cm in females or ≥102cm in males
  • Have Wi-Fi high speed internet
  • Able to obtain medical clearance from doctor
  • Have less than a 5% weight loss in past 6 months
  • No advanced co-morbidity
  • No exercise restrictions
  • Not involved in other research studies that may interfere with participation

You may not qualify if:

  • Severe mental or life-threatening illness
  • Dementia
  • Substance use
  • History of bariatric surgery
  • Suicidal ideation
  • Unable to perform measures
  • Reside in nursing home
  • No advanced co-morbidity
  • No exercise restrictions
  • Not involved in other research studies that may interfere with participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03766, United States

Location

Related Publications (1)

  • Batsis JA, Petersen CL, Clark MM, Cook SB, Kotz D, Gooding TL, Roderka MN, Al-Nimr RI, Pidgeon D, Haedrich A, Wright KC, Aquila C, Mackenzie TA. Feasibility and acceptability of a technology-based, rural weight management intervention in older adults with obesity. BMC Geriatr. 2021 Jan 12;21(1):44. doi: 10.1186/s12877-020-01978-x.

Related Links

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Results Point of Contact

Title
John A. Batsis
Organization
Dartmouth-Hitchcock

Study Officials

  • John A Batsis, MD

    Dartmouth-Hitchcock Medical Center / Dartmouth Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: A single arm pilot intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine and of The Dartmouth Institute Geisel School of Medicine at Dartmouth

Study Record Dates

First Submitted

April 3, 2017

First Posted

April 7, 2017

Study Start

October 1, 2018

Primary Completion

July 1, 2020

Study Completion

July 31, 2021

Last Updated

June 12, 2023

Results First Posted

December 20, 2021

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations